Demodex blepharitis affects about 58% of patients, necessitating thorough ocular surface examinations for accurate diagnosis ...
The FDA approved lotilaner ophthalmic solution 0.25% (Xdemvy) as the first specific treatment for Demodex blepharitis. Lotilaner (formerly TP-03) is an ectoparasiticide that targets Demodex mites, ...
AJMC®: Does the prevalence of Demodex blepharitis found by Trattler and colleagues 1 match what you see in clinical practice? BRUJIC: The prevalence of Demodex blepharitis is interesting. Prior to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback